- Home
- WRBY vs RCKT Comparison
WRBY vs RCKT Comparison
Compare WRBY & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- RCKT
- Stock Information
- Founded
- WRBY 2010
- RCKT 1999
- Country
- WRBY United States
- RCKT United States
- Employees
- WRBY N/A
- RCKT N/A
- Industry
- WRBY Ophthalmic Goods
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- WRBY Health Care
- RCKT Health Care
- Exchange
- WRBY Nasdaq
- RCKT Nasdaq
- Market Cap
- WRBY 2.7B
- RCKT 264.0M
- IPO Year
- WRBY 2021
- RCKT N/A
- Fundamental
- Price
- WRBY $22.19
- RCKT $2.99
- Analyst Decision
- WRBY Buy
- RCKT Buy
- Analyst Count
- WRBY 16
- RCKT 13
- Target Price
- WRBY $23.33
- RCKT $18.50
- AVG Volume (30 Days)
- WRBY 1.9M
- RCKT 3.8M
- Earning Date
- WRBY 08-07-2025
- RCKT 08-04-2025
- Dividend Yield
- WRBY N/A
- RCKT N/A
- EPS Growth
- WRBY N/A
- RCKT N/A
- EPS
- WRBY N/A
- RCKT N/A
- Revenue
- WRBY $795,094,000.00
- RCKT N/A
- Revenue This Year
- WRBY $16.13
- RCKT N/A
- Revenue Next Year
- WRBY $13.87
- RCKT N/A
- P/E Ratio
- WRBY N/A
- RCKT N/A
- Revenue Growth
- WRBY 13.94
- RCKT N/A
- 52 Week Low
- WRBY $12.46
- RCKT $2.19
- 52 Week High
- WRBY $28.68
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- WRBY 57.54
- RCKT 45.55
- Support Level
- WRBY $21.13
- RCKT $2.76
- Resistance Level
- WRBY $22.72
- RCKT $3.24
- Average True Range (ATR)
- WRBY 0.84
- RCKT 0.19
- MACD
- WRBY -0.09
- RCKT 0.17
- Stochastic Oscillator
- WRBY 71.85
- RCKT 74.85
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.